Furthermore, increased expression of apoptosis markers caspase 3 and cleaved caspase 3 in tumors, suggests the additive effect of HER2-DC1 i.t. combined with anti-HER2 antibodies treatment in mediating HER2pos tumor regression (figure 6F). Here, CASP3 is linked to neoplasm.